HomeJUNE Medical GroupNew eVeck™ from JUNE Medical Offers Protection from Surgical Plume

New eVeck™ from JUNE Medical Offers Protection from Surgical Plume

eVeck™ from JUNE Medical Colposcopy Plume Evacuation Kit launches in response to recent legislation in several US states, directed at protecting medical staff and patients from dangerous constituents in surgical smoke.

eVeck™ from JUNE Medical

The state of Oregon has joined Rhode Island, Colorado, and Kentucky in efforts to minimize exposure to hazardous gas created during surgical procedures; from the 1st of January 2023 it will be a legal requirement for all licensed hospitals and surgical facilities in these states to use a smoke evacuation system during certain procedures that produce surgical plume. Surgical plume is created during electrocautery, laser surgery or the use of ultrasonic scalpels, and can be dangerous to both the staff and patients since it contains carcinogens, toxic gases and pathogens.

The eVeck kit is designed to connect a colposcopy speculum to a plume evacuation generator to filter out toxic or carcinogenic matter within the smoke. The HEPA™ filter, which is included in the kit, comes already assembled and its reinforced tubing prevents kinking and crushing. The kit will be available for purchase in the US, helping medical facilities to comply with the new regulations.

Angela Spang, CEO of JUNE Medical, said: “Surgical plume is present in many procedures that are performed on a daily basis and, without proper smoke evacuation, the surgeons and nurses have to put their own health at risk every time they enter the operating theater. I am therefore very happy that JUNE Medical can offer protection from this occupational hazard to medical personnel all over the US.”

First launched in 2020.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy